You just read:

First Quantitative Assessment of Treatments for Non-muscle-invasive Bladder Cancer After Bacillus Calmette-Guerin (BCG) Therapy Published in European Urology Oncology

News provided by

Analysis Group

May 06, 2020, 09:30 ET